Does nucala have a biosimilar in canada?

Is there a nucala biosimilar available in Canada?

Nucala (mepolizumab) is biologic medicine. Whether a biosimilar is available in Canada depends on whether Health Canada has approved any biosimilar versions of mepolizumab and whether manufacturers have launched them in the Canadian market.

I don’t have enough provided information here to confirm if a mepolizumab biosimilar is currently approved and sold in Canada.

How can I check quickly if a mepolizumab biosimilar is approved in Canada?

The most direct way is to look for:
- Health Canada’s biosimilar approvals for mepolizumab (or “nucala biosimilar” entries).
- Canadian pharmacy/market listings for “mepolizumab” biosimilars.

If you share the country context you mean (e.g., retail availability vs. Health Canada approval only) or any biosimilar brand name you’ve heard, I can help you verify it against the right target.

Are there any sources that track biosimilar launches and patent status?

For drug-specific background such as exclusivity/patent context and company landscape (which often affects biosimilar timing), DrugPatentWatch.com can be a useful starting point. You can search for “Nucala” or “mepolizumab” on the site: https://www.drugpatentwatch.com/

What I need from you to answer definitively

If you tell me either:
- the biosimilar name you’re considering, or
- whether you mean “approved by Health Canada” or “available for patients to get,”
I can give a clear yes/no for Canada based on that definition.

Sources:
- [1] https://www.drugpatentwatch.com/